UPC (Universe Pharmaceuticals) Interest Expense: $-0.23 Mil (TTM As of Sep. 2025)


UPC Universe Pharmaceuticals Inc UPC
58 GF Score
Price $2.96
GF Value $5.22
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Interest Expense?

Universe Pharmaceuticals UPC +6.86% 58 Interest Expense is $-0.23 Mil as of Sep. 2025. GuruFocus rates UPC with a GF Score™ of 58/100 and a GF Value™ of $5.22 (Possible Value Trap). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Universe Pharmaceuticals's interest expense for the six months ended in Sep. 2025 was $ -0.10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.23 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Universe Pharmaceuticals's Operating Income for the six months ended in Sep. 2025 was $ -0.59 Mil. Universe Pharmaceuticals's Interest Expense for the six months ended in Sep. 2025 was $ -0.10 Mil. Universe Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Universe Pharmaceuticals  (NAS:UPC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Universe Pharmaceuticals's Interest Expense for the six months ended in Sep. 2025 was $-0.10 Mil. Its Operating Income for the six months ended in Sep. 2025 was $-0.59 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2025 was $0.00 Mil.

Universe Pharmaceuticals's Interest Coverage for the quarter that ended in Sep. 2025 is calculated as

Universe Pharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Universe Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Interest Expense Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Interest Expense
Get a 7-Day Free Trial -0.10 -0.16 -0.16 -0.28 -0.23

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.14 -0.14 -0.13 -0.10
UPC
58GF Score
Universe Pharmaceuticals Inc UPC
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universe Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.23 Mil mean?
Universe Pharmaceuticals (UPC) has a Interest Expense of $-0.23 Mil as of Sep. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Universe Pharmaceuticals and its competitors.
Is Universe Pharmaceuticals' Interest Expense too high?
Universe Pharmaceuticals' current Interest Expense is $-0.23 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Interest Expense compare to CBIH and PRFX?
Universe Pharmaceuticals' Interest Expense of $-0.23 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Universe Pharmaceuticals and its competitors. Universe Pharmaceuticals's current Interest Expense is $-0.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Possible Value Trap. The stock's GF Value™ is $5.22, compared to a current price of $2.96 — trading 43.3% below its estimated fair value. The current Interest Expense is $-0.23 Mil. Universe Pharmaceuticals' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Interest Expense is $-0.23 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be undervalued. The current stock price of $2.96 is trading 43.3% below its estimated GF Value™ of $5.22. GuruFocus considers Universe Pharmaceuticals to be Possible Value Trap.

Key valuation signals for UPC:

  • Interest Expense: $-0.23 Mil
  • GF Value™: $5.22 vs. price of $2.96 (43.3% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
58GF Score

Get the complete analysis for UPC

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.96
Price
$5.22
GF Value